HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Radioguidance for nonpalpable primary lesions and sentinel lymph node(s).

AbstractBACKGROUND:
Radioguided surgery can also be used for the simultaneous guidance to a nonpalpable primary tumor and sentinel lymph nodes.
METHODS:
Retrospective review of a prospective database. The surgeon used a gamma probe for guidance to an iodine-125 labeled titanium seed at the primary lesion and technetium-99 labeled sulfur colloid at the sentinel lymph node.
RESULTS:
Forty-three patients with nonpalpable breast carcinoma underwent dual isotope radioguided surgery. The radioactive seed and primary lesion were retrieved in the first excision in all 44 patients (100%). Eleven patients (25%) had pathologically involved margins. Sentinel lymph node mapping was successful in 42 patients (98%). A mean of 2.4 sentinel nodes were excised and metastatic carcinoma was present in four patients (10%).
CONCLUSIONS:
Dual isotopes can be effectively used in breast cancer patients for simultaneous radioguidance to both a nonpalpable primary lesion and sentinel lymph node and allows for improved logistics.
AuthorsR J Gray, R Giuliano, E L Dauway, C E Cox, D S Reintgen
JournalAmerican journal of surgery (Am J Surg) Vol. 182 Issue 4 Pg. 404-6 (Oct 2001) ISSN: 0002-9610 [Print] United States
PMID11720680 (Publication Type: Journal Article)
Chemical References
  • Iodine Radioisotopes
  • Technetium Tc 99m Sulfur Colloid
Topics
  • Breast Neoplasms (diagnostic imaging, pathology, surgery)
  • Female
  • Humans
  • Iodine Radioisotopes
  • Lymph Node Excision
  • Lymph Nodes (diagnostic imaging)
  • Lymphatic Metastasis (diagnostic imaging)
  • Radionuclide Imaging
  • Retrospective Studies
  • Sentinel Lymph Node Biopsy
  • Technetium Tc 99m Sulfur Colloid

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: